Remdesivir for Patients Hospitalized with COVID-19 Severe Pneumonia: A National Cohort Study (Remdeco-19).

Jeremie ZerbitMarion DetroitSylvie ChevretFrederic PeneCharles-Edouard LuytJade GhosnFrederic EyvrardGuillaume Martin-BlondelBenjamine SartonRaphael Clere-JehlPierre MoineAmélie CransacPascal AndreuMarie LabruyèreLaetitia AlbertiniJean-François HuonPauline RogeLise BernardMagali Farines-RaffoulMaxime VillietArnaud VenetLouis Marie DumontJean-Daniel KaiserClaire ChapuisFrançois GoehringerFrançois BarbierStephane DesjardinsYounes BenzidiNora AbbasCorinne GuerinRui BatistaJean-François LlitjosMarie Kroemer

Published in: Journal of clinical medicine (2022)

SOFA score appeared to be an attractive approach to assess remdesivir efficacy and stratify its utilization or not in critically ill patients with COVID-19. This study brings a new clinical benchmark for therapeutic decision making and supports the use of remdesivir for some hospitalized COVID-19 patients.

Keyphrases

sars cov
end stage renal disease
coronavirus disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
early onset
quality improvement
patient reported outcomes
patient reported